Lupin gets USFDA nod to market its mania and epilepsy treatment drug in US
Posted by
www.biotecnika.org
The company has received approval from the United States Food and Drug
Administration (USFDA) for its Divalproex Sodium extended-release
tablets in the strengths of 250 mg and 500 mg, Lupin said in a
statement.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-gets-usfda-nod-to-market-its-mania-and-epilepsy-treatment-drug-in-us/articleshow/71706379.cms
Subscribe to:
Post Comments (Atom)
Post a Comment